US FDA brass pushed internally for speedier Lilly weight-loss pill verdict
Dec 12 (Reuters) - Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's LLY.N experimental weight‑loss pill, after the company pushed for a faster timeline, documents seen by Reuters show.
ReutersFri, Dec 12